Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2021
Circulating tumor DNA in patients with metastatic prostate cancer treated with abiraterone acetate
Y Loriot, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2025
The next-generation of nectin-4 targeted therapies
C Pobel, Y Loriot
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?
Y Loriot, P Mordant, E Deutsch
Bulletin Du Cancer
|
December 26, 2009
[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value]
D Planchard, Y Loriot, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2012
Recent developments in treatments targeting castration-resistant prostate cancer bone metastases
Y Loriot, C Massard, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2022
FIGHT against FGF/FGFR alterations: what are the next steps?
A Bayle, P Martin-Romano, Y Loriot
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Expanding role of chemotherapy in lung cancer
Y Loriot, J-C Soria, T Le Chevalier
Bulletin Du Cancer
|
December 26, 2009
[Targeting KRAS pathway in NSCLC therapy]
S Le Moulec, Y Loriot, J-C Soria
Lancet (London, England)
|
August 30, 2008
MVP and vinorelbine for malignant pleural mesothelioma
P Mordant, Y Loriot, J C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel and bone-targeted agents for CRPC
K Fizazi, L Albiges, C Massard, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2021
Circulating tumor DNA in patients with metastatic prostate cancer treated with abiraterone acetate
Y Loriot, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2025
The next-generation of nectin-4 targeted therapies
C Pobel, Y Loriot
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?
Y Loriot, P Mordant, E Deutsch
Bulletin Du Cancer
|
December 26, 2009
[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value]
D Planchard, Y Loriot, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2012
Recent developments in treatments targeting castration-resistant prostate cancer bone metastases
Y Loriot, C Massard, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2022
FIGHT against FGF/FGFR alterations: what are the next steps?
A Bayle, P Martin-Romano, Y Loriot
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Expanding role of chemotherapy in lung cancer
Y Loriot, J-C Soria, T Le Chevalier
Bulletin Du Cancer
|
December 26, 2009
[Targeting KRAS pathway in NSCLC therapy]
S Le Moulec, Y Loriot, J-C Soria
Lancet (London, England)
|
August 30, 2008
MVP and vinorelbine for malignant pleural mesothelioma
P Mordant, Y Loriot, J C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel and bone-targeted agents for CRPC
K Fizazi, L Albiges, C Massard, et al.
Page
of 8